PPAR-γ Inhibits Chronic Apical Periodontitis by Facilitating Macrophage Efferocytosis
International Journal of Molecular Sciences · 19.10.2025 · 26 (20) · 10157
DOI: 10.3390/ijms262010157 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.10.2025. Verfasst von Yuting Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an 710049, Chi…. Hauptthemen laut MEDLINE: PPAR gamma, Macrophages, Periapical Periodontitis, Phagocytosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central Universities, Xi'an Jiaotong University, Fundamental Research Funds for the Central Universities, Xi’an Jiaotong University.
Abstract (Originalsprache)
This study aimed to elucidate the role of peroxisome proliferator-activated receptor-γ (PPAR-γ) in regulating macrophage efferocytosis during the pathogenesis of chronic apical periodontitis (CAP). Clinical specimens, rat periapical lesion models, and an in vitro model simulating the CAP inflammatory milieu were employed to examine the contribution of PPAR-γ to efferocytosis throughout disease progression. The expression of PPAR-γ in vivo was assessed by single-cell RNA sequencing and immunohistochemical (IHC) staining. Pearson’s correlation and linear trend tests were conducted to investigate the association between PPAR-γ and macrophage efferocytosis during CAP progression. Pharmacological modulation of PPAR-γ was further conducted using rosiglitazone (RSG) as an agonist and GW9662 as an antagonist, followed by an assessment of efferocytosis-related parameters and inflammatory responses. Both clinical specimens and animal models demonstrated a progressive reduction in PPAR-γ expression and macrophage efferocytosis during CAP. Notably, PPAR-γ attenuated efferocytosis impairment and significantly reduced pathogen-induced inflammatory responses in macrophages. These findings indicate that defective macrophage efferocytosis contributes to the exacerbation of CAP severity, whereas targeting PPAR-γ may represent a promising therapeutic strategy to alleviate inflammation in periapical lesions by restoring efferocytic capacity. Collectively, this study highlights PPAR-γ as a potential therapeutic target warranting further investigation in CAP treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an 710049, China.
- Clinical Research Center of Shaanxi Province for Dental and Maxillofacial Diseases, College of Stomatology, Xi'an Jiaotong University, Xi'an 710049, China.
- Department of Cariology and Endodontics, College of Stomatology, Xi'an Jiaotong University, Xi'an 710049, China.
Förderung
- the Fundamental Research Funds for the Central Universities, Xi'an Jiaotong University
- Fundamental Research Funds for the Central Universities, Xi’an Jiaotong University
Zitieren
APA
Wang, Y., Wang, M., Jia, X., Tang, Y., Wang, J., Zhang, W., Hou, T., & Guan, X. (2025). PPAR-γ Inhibits Chronic Apical Periodontitis by Facilitating Macrophage Efferocytosis. International Journal of Molecular Sciences, 26(20), 10157. https://doi.org/10.3390/ijms262010157
Vancouver
Wang Y, Wang M, Jia X, Tang Y, Wang J, Zhang W, et al. PPAR-γ Inhibits Chronic Apical Periodontitis by Facilitating Macrophage Efferocytosis. International Journal of Molecular Sciences. 2025;26(20):10157. doi:10.3390/ijms262010157
BibTeX
@article{Wang2025,
author = {Wang, Yuting and Wang, Mingfei and Jia, Xiaowen and Tang, Yifei and Wang, Jiayi and Zhang, Wenjiao and Hou, Tiezhou and Guan, Xiaoyue},
title = {PPAR-γ Inhibits Chronic Apical Periodontitis by Facilitating Macrophage Efferocytosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {10157},
doi = {10.3390/ijms262010157}
}
EUVIMED